NewAmsterdam Pharma (NAMS) EBIT (2023 - 2026)
NewAmsterdam Pharma (NAMS) recorded EBIT of -$64.86 million in Q2 2026, compared with -$35.64 million a year earlier.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) EBIT (2023 - 2026) Analysis & Trends
On a TTM basis, NewAmsterdam Pharma's EBIT came in at -$244.41 million as of Jun 30, 2026; for FY2025, it was -$225.68 million.
- Across earlier years, EBIT came in at -$176.29 million in FY2024, -$182.97 million in FY2023, -$3.56 million in FY2022 and -$34.98 million in FY2021.
- Quarterly EBIT has ranged from -$68.93 million in Q1 2025 to -$25 million in Q3 2024 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$58.42 million (Q1 2026), -$65.98 million (Q4 2025) and -$55.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | NewAmsterdam Pharma | 2.43 Bn | -108.81 Mn | - | -44.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -44.19 Mn |
| Jun 30, 2026 | -64.86 Mn |
| Mar 31, 2026 | -58.42 Mn |
| Dec 31, 2025 | -65.98 Mn |
| Sep 30, 2025 | -55.14 Mn |
| Jun 30, 2025 | -35.64 Mn |
| Mar 31, 2025 | -68.93 Mn |
| Dec 31, 2024 | -43.23 Mn |
| Sep 30, 2024 | -25.00 Mn |
| Jun 30, 2024 | -52.58 Mn |
| Mar 31, 2024 | -55.48 Mn |
| Dec 31, 2023 | -51.07 Mn |
| Sep 30, 2023 | -49.56 Mn |
| Jun 30, 2023 | -42.48 Mn |
| Mar 31, 2023 | -39.85 Mn |
API Access
NewAmsterdam Pharma EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();